Develops a semi-automated HyperTherm platform for oncology providing real-time, software-based thermal mapping and highly accurate patient temperature control during hyperthermal therapy. Targets advanced solid cancer patients unresponsive to or unsuitable for standard therapies, aiming to boost conventional anticancer treatments and improve quality of life and survival.